FindTrial
Sign In

The role of serum interleukin-6 level in predicting the postoperative complications after ovarian cancer surgery

Serum interleukin-6 (IL-6) levels in prognosticating postoperative complications after ovarian cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013162
Enrollment
50
Registered
2018-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- carcinoma ovary Health Condition 2: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

Dr Vibhavari Naik
Lead Sponsor
Dr D Radharani
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All Carcinoma Ovary patients posted for ovarian cytoreduction surgery will be included

Exclusion criteria

Exclusion criteria: Patients posted for emergency procedures will be excluded Patients who refuse to consent

Design outcomes

Primary

MeasureTime frame
Mortality ComplicationsTimepoint: During hospital stay—

Secondary

MeasureTime frame
Length of ICU stay Length of Hospital stayTimepoint: During hospital stay—

Countries

India

Contacts

Public ContactDr Vibhavari Naik

Basavatarakam Indo-American Cancer Hospital and Research Institute

vibnaik@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026